El-Nagdy Ahmed Hazem, Abdel-Fattah Gamal M, Emarah Ziad
Microbiology Department, Faculty of Dentistry, Horus University, Damietta el gadeeda, Egypt.
Botany Department, Faculty of Science, Mansoura University, Mansoura, Egypt.
Infect Drug Resist. 2020 Sep 7;13:3091-3101. doi: 10.2147/IDR.S259914. eCollection 2020.
Febrile neutropenia (FN) is the evolution of fever in a patient with neutropenia over 38.0°C. Neutropenia is diagnosed when absolute neutrophil count (ANC) <1500 cells/µL. FN represents a common complication of cancer treatment. Hence, it is featured to be a major cause of morbidity and mortality in cancer patients. is one of the most important microorganisms isolated from the blood of febrile neutropenic patients. Infections caused by range from mild to life-threatening diseases. Biofilm production by is one of the most significant virulence factors of the bacterium as it prevents the penetration of antibiotics. Recently, it has been shown that carries the operon responsible for biofilm production. The aim of the work is to determine a genotypic characterization that includes not only the detection of and genes in but also the determination of their relation to clinical and microbiological features. Empiric antibacterial treatment was recommended for cancer patients receiving chemotherapy.
The relation between the presence of and and biofilm production was determined in a collection of 66 samples from febrile neutropenic patients. Biofilm-forming ability was tested on Congo Red agar plates. Also, the effect of the most sensitive antibiotics on the bacterial cells was determined by an electron microscope.
Of the bacterial samples, 48 were biofilm-productive and 18 were non-biofilm productive. For the biofilm productive bacteria, 37.5% were positive for , 22.9% were positive for and 10.4% were positive for both. Linezolid was the most effective antibiotic and it is highly recommended for the treatment of febrile neutropenia caused by biofilm-productive . Severe changes were found on the bacterial cell after being treated with Linezolid. The and genes were present in only 50% of biofilm-productive bacteria.
The operon is present in only 50% of biofilm-productive and Linezolid is the best antibiotic against these bacteria.
发热性中性粒细胞减少症(FN)是指中性粒细胞减少的患者体温超过38.0°C时出现发热。当中性粒细胞绝对计数(ANC)<1500个细胞/微升时可诊断为中性粒细胞减少症。FN是癌症治疗的常见并发症。因此,它是癌症患者发病和死亡的主要原因之一。[细菌名称]是从发热性中性粒细胞减少症患者血液中分离出的最重要的微生物之一。由[细菌名称]引起的感染范围从轻度到危及生命的疾病。[细菌名称]产生生物膜是该细菌最重要的毒力因子之一,因为它会阻止抗生素的渗透。最近的研究表明,[细菌名称]携带负责生物膜产生的[基因名称]操纵子。这项工作的目的是确定一种基因型特征,不仅包括检测[细菌名称]中的[基因名称1]和[基因名称2]基因,还包括确定它们与临床和微生物学特征的关系。对于接受化疗的癌症患者,建议进行经验性抗菌治疗。
在一组来自发热性中性粒细胞减少症患者的66份[细菌名称]样本中,确定了[基因名称1]和[基因名称2]的存在与生物膜产生之间的关系。在刚果红琼脂平板上测试生物膜形成能力。此外,通过电子显微镜确定最敏感抗生素对细菌细胞的作用。
在细菌样本中,48份具有生物膜产生能力,18份不具有生物膜产生能力。对于具有生物膜产生能力的细菌,37.5%的[基因名称1]呈阳性,22.9%的[基因名称2]呈阳性,10.4%的两者均呈阳性。利奈唑胺是最有效的抗生素,强烈推荐用于治疗由具有生物膜产生能力的[细菌名称]引起的发热性中性粒细胞减少症。用利奈唑胺治疗后,细菌细胞出现严重变化。[基因名称1]和[基因名称2]基因仅存在于50%具有生物膜产生能力的细菌中。
[基因名称]操纵子仅存在于50%具有生物膜产生能力的[细菌名称]中,利奈唑胺是对抗这些细菌的最佳抗生素。